Beijing Ql Biopharmaceutical Co.,ltd

This study tested an experimental injection called ZT002 in 303 adults who are overweight or have obesity. The goal was to see how much weight people lost after 24 weeks of treatment compared to a placebo. The study also looked at how many people lost at least 5%, 10%, or 15% of …

This early-stage study tested the safety and tolerability of a new injectable drug called ZT002 in 28 adults who were overweight or obese. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The g…

This early-stage study tested a new daily pill, ZT006, in 94 healthy, overweight, and obese adults. The main goal was to check safety and how the drug moves through the body, not to prove weight loss. Participants received either the drug or a placebo, and some took it with food …